CMI Insider Files Rule 144 to Sell 4,850 Shares on NYSE
Rhea-AI Filing Summary
Cummins Inc. filed a Form 144 disclosing a proposed sale of 4,850 shares of common stock through Morgan Stanley Smith Barney on the NYSE, showing an aggregate market value of 1,887,560.35 and 137,786,038 shares outstanding. The table reports the shares were acquired and paid for on 08/08/2025 by exercise of options under a registered plan, with payment in cash, and lists the approximate date of sale as 08/08/2025. The filing states there were no securities sold during the past three months by the person for whose account the sale is reported and includes the standard attestation that the signer does not possess undisclosed material adverse information. The notice records a routine, reported insider exercise-and-sale under Rule 144.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider exercise-and-sale disclosed; transaction size is small relative to total shares outstanding and appears procedural.
The filing documents a proposed sale of 4,850 common shares with an aggregate market value of 1,887,560.35, routed through Morgan Stanley Smith Barney and slated for 08/08/2025. The shares were acquired the same day by exercising options under a registered plan and paid in cash, and no other sales by the same person are reported in the prior three months. For investors, this is a compliance disclosure of an insider liquidity event rather than a corporate operational development and is not materially informative about company performance.
TL;DR: Filing demonstrates Rule 144 procedural compliance and includes the seller's representation about material non-public information.
The Form 144 shows the transaction was processed through an institutional broker and records the acquisition method as option exercise under a registered plan, with cash payment and same-day sale timing. The form explicitly notes no securities sold in the past three months for the reporting person and contains the customary signature attestation regarding absence of undisclosed material adverse information. From a governance standpoint, the filing meets routine disclosure expectations for an officer or insider executing pre-registered option exercises and subsequent sales.